COVID-19
5,284
143
277
2,872
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
631 trials with published results (12%)
Research Maturity
2872 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
407 terminated out of 5284 trials
87.6%
+1.0% vs benchmark
13%
666 trials in Phase 3/4
22%
631 of 2872 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2872 completed trials
Clinical Trials (5284)
Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
COVID-19 Experiences in the SELF Cohort
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
Different Treatment Options Used for Post Covid-19 Syndrome
Chinese Medicine for Patients With LCOVID-19 Symptoms
Genetics of COVID-19 Susceptibility and Manifestations
Leveraging Social Networks to Increase COVID-19 Testing Uptake
Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era
Treatment and Outcomes in Patients With COVID-19 and Competing Acute Surgical Diseases in Moscow
Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana
COVID-19 Vaccine Uptake Trial